roflumilast 0.25 MG Oral Tablet [Daliresp]

RxNorm concept 2001321, branded drug (sbd). Prescribable name: Daliresp 250 MCG Oral Tablet.

RxCUI: 2001321
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2001321 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

roflumilast 1091836

Other names

Daliresp 0.25 MG Oral Tablet; Daliresp 250 MCG Oral Tablet

Related concepts

roflumilast 0.25 MG (SCDC, consists of)
roflumilast 0.25 MG [Daliresp] (SBDC, consists of)
Oral Tablet (DF, has dose form)
Daliresp (BN, has ingredient)
roflumilast 0.25 MG Oral Tablet (SCD, tradename of)

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2001321 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2001321 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2001321. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.